ULO
Pre-Launchchlophedianol hydrochloride
NDAORALSYRUP
Lifecycle
Pre-Launch
Clinical Trials
20
Data completeness
1/8 — Limited
Drug data last refreshed 17h ago · AI intelligence enriched 19h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ULO (chlophedianol hydrochloride) is an oral syrup small-molecule antitussive agent currently in pre-launch development stage. Chlophedianol is a non-narcotic cough suppressant indicated for symptomatic relief of cough. The drug works through central nervous system depression of the cough reflex center.
Pre-Launch
Early-stage development offers opportunity to build commercial infrastructure and brand positioning from inception.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
Expanded Access Use of Sulopenem Etzadroxil/Probenecid for Complicated Urinary Tract Infection
Complicated Urinary Tract InfectionAcute Pyelonephritis
A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy
Mycobacterium Avium-Intracellulare InfectionHIV InfectionsTuberculosis, Mycobacterium Infection
Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis
50 enrolled
HIV InfectionsTuberculosis
A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma
18 enrolled
Sarcoma, KaposiHIV Infections
A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin
44 enrolled
HIV InfectionsTuberculosis
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.